{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:52:40Z","timestamp":1791049960487,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T00:00:00Z","timestamp":1545523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Guangdong Key Laboratory of Male Reproductive Medicine and Genetics","award":["2017B030314074"],"award-info":[{"award-number":["2017B030314074"]}]},{"name":"Shenzhen Science and Technology Project","award":["JCYJ20170413100245260"],"award-info":[{"award-number":["JCYJ20170413100245260"]}]},{"name":"Shenzhen \u2018San-ming\u2019 Medical Project","award":["SZSM201612066"],"award-info":[{"award-number":["SZSM201612066"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.biopha.2018.12.102","type":"journal-article","created":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T04:59:38Z","timestamp":1545973178000},"page":"517-526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1)"],"prefix":"10.1016","volume":"111","author":[{"given":"Yawen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changshui","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiefu","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengle","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfa","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinbo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoting","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.12.102_bib0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G","article-title":"The Heidelberg classification of renal cell tumours","volume":"183","author":"Kovacs","year":"1997","journal-title":"J. Pathol."},{"key":"10.1016\/j.biopha.2018.12.102_bib0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ccr.2004.09.006","article-title":"Focus on kidney cancer","volume":"6","author":"Linehan","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2018.12.102_bib0015","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(09)60229-4","article-title":"Renal cell carcinoma","volume":"373","author":"Rini","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2018.12.102_bib0020","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.eururo.2015.01.005","article-title":"EAU guidelines on renal cell carcinoma: 2014 update","volume":"67","author":"Ljungberg","year":"2015","journal-title":"Eur. Urol."},{"key":"10.1016\/j.biopha.2018.12.102_bib0025","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.clgc.2013.04.018","article-title":"Adjuvant treatment for resected renal cell carcinoma: are all strategies equally negative? Potential implications for trial design with targeted agents","volume":"11","author":"Massari","year":"2013","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.biopha.2018.12.102_bib0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2018.12.102_bib0035","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13045-015-0129-1","article-title":"Competing endogenous RNA networks: tying the essential knots for cancer biology and therapeutics","volume":"8","author":"Sanchez-Mejias","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2018.12.102_bib0040","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/mrd.22678","article-title":"Function and regulation of microRNA-31 in development and disease","volume":"83","author":"Stepicheva","year":"2016","journal-title":"Mol. Reprod. Dev."},{"key":"10.1016\/j.biopha.2018.12.102_bib0045","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/35077213","article-title":"Proliferation, cell cycle and apoptosis in cancer","volume":"411","author":"Evan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2018.12.102_bib0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1385\/MB:32:3:227","article-title":"Control of the G2\/M transition","volume":"32","author":"Stark","year":"2006","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.biopha.2018.12.102_bib0055","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1186\/1471-2407-14-951","article-title":"High nuclear\/cytoplasmic ratio of Cdk1 expression predicts poor prognosis in colorectal cancer patients","volume":"14","author":"Sung","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2018.12.102_bib0060","article-title":"Loss of cytoplasmic CDK1 predicts poor survival in human lung cancer and confers chemotherapeutic resistance","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.12.102_bib0065","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.urolonc.2014.05.006","article-title":"CDK1 and CDK2 activity is a strong predictor of renal cell carcinoma recurrence","volume":"32","author":"Hongo","year":"2014","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.biopha.2018.12.102_bib0070","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000012140","article-title":"Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma","volume":"59","author":"Ito","year":"2000","journal-title":"Oncology"},{"issue":"1","key":"10.1016\/j.biopha.2018.12.102_bib0075","doi-asserted-by":"crossref","first-page":"R121","DOI":"10.1093\/hmg\/ddi101","article-title":"Small regulatory RNAs in mammals","volume":"14","author":"Mattick","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biopha.2018.12.102_bib0080","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1044-579X(03)00038-5","article-title":"MicroRNAs and cancer","volume":"13","author":"McManus","year":"2003","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.biopha.2018.12.102_bib0085","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5348490","article-title":"MicroRNA-31 function as a suppressor was regulated by epigenetic mechanisms in gastric cancer","volume":"2017","author":"Wei","year":"2017","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.biopha.2018.12.102_bib0090","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.bbrc.2017.06.050","article-title":"Increased expression of microRNA-31-5p inhibits cell proliferation, migration, and invasion via regulating Sp1 transcription factor in HepG2 hepatocellular carcinoma cell line","volume":"490","author":"Zhao","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2018.12.102_bib0095","article-title":"miR-31 functions as an oncomir which promotes epithelial-mesenchymal transition via regulating BAP1 in cervical cancer","volume":"2017","author":"Wang","year":"2017","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.biopha.2018.12.102_bib0100","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3892\/ol.2017.5554","article-title":"MicroRNA-31 functions as an oncogenic microRNA in cutaneous squamous cell carcinoma cells by targeting RhoTBT1","volume":"13","author":"Lin","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2018.12.102_bib0105","article-title":"Prognostic value of RNASEH2A-, CDK1-, and CD151-Related pathway gene profiling for kidney cancers","volume":"19","author":"Yang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2018.12.102_bib0110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrd4504","article-title":"The history and future of targeting cyclin-dependent kinases in cancer therapy","volume":"14","author":"Asghar","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2018.12.102_bib0115","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/jjco\/hyw085","article-title":"Serum microRNA expression profile as a diagnostic panel for gastric cancer","volume":"46","author":"Huang","year":"2016","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2018.12.102_bib0120","doi-asserted-by":"crossref","first-page":"36577","DOI":"10.18632\/oncotarget.9288","article-title":"Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2018.12.102_bib0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/OTT.S155016","article-title":"Four-miRNA signature as a prognostic tool for lung adenocarcinoma","volume":"11","author":"Lin","year":"2018","journal-title":"Onco. Ther."},{"key":"10.1016\/j.biopha.2018.12.102_bib0130","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.jid.2018.03.1521","article-title":"MiR-31 mediates inflammatory signaling to promote re-epithelialization during skin wound healing","volume":"138","author":"Shi","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.biopha.2018.12.102_bib0135","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1002\/jcb.26830","article-title":"Aberrant expression of LncRNA-MIR31HG regulates cell migration and proliferation by affecting miR-31 and miR-31* in Hirschsprung\u2019s disease","volume":"119","author":"Cai","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2018.12.102_bib0140","doi-asserted-by":"crossref","DOI":"10.3390\/genes9020085","article-title":"MicroRNA-31 and MicroRNA-155 are overexpressed in ulcerative colitis and regulate IL-13 signaling by targeting interleukin 13 receptor alpha-1","volume":"9","author":"Gwiggner","year":"2018","journal-title":"Genes"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218369038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218369038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:35:25Z","timestamp":1760096125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218369038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":28,"alternative-id":["S0753332218369038"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.12.102","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1)","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.12.102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}